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Abstract
Background: Lebercongenitalamaurosis(LCA)isthe earliestonsetandmostsevereformof hereditaryretinaldystrophy. So far,
fullspectrumofvariationsinthe15genesknowntocauseLCAhasnotbeensystemicallyevaluatedinEastAsians.Therefore,we
performed comprehensive detection of variants in these 15 genes in 87 unrelated Han Chinese patients with LCA.
Methodology/Principal Findings: The 51 most frequently mutated exons and introns in the 15 genes were selected for an
initial scan using cycle sequencing. All the remaining exons in 11 of the 15 genes were subsequently sequenced. Fifty-three
different variants were identified in 44 of the 87 patients (50.6%), involving 78 of the 88 alleles (11 homozygous and 56
heterozygous variants). Of the 53 variants, 35 (66%) were novel pathogenic mutations. In these Chinese patients, variants in
GUCY2D are the most common cause of LCA (16.1% cases), followed by CRB1 (11.5%), RPGRIP1 (8%), RPE65 (5.7%), SPATA7
(4.6%), CEP290 (4.6%), CRX (3.4%), LCA5 (2.3%), MERTK (2.3%), AIPL1 (1.1%), and RDH12 (1.1%). This differs from the variation
spectrum described in other populations. An initial scan of 55 of 215 PCR amplicons, including 214 exons and 1 intron,
detected 83.3% (65/78) of the mutant alleles ultimately found in these 87 patients. In addition, sequencing only 9 exons
would detect over 50% of the identified variants and require less than 5% of the labor and cost of comprehensive
sequencing for all exons.
Conclusions/Significance: Our results suggest that specific difference in the variation spectrum found in LCA patients from
the Han Chinese and other populations are related by ethnicity. Sequencing exons in order of decreasing risk is a cost-
effective way to identify causative mutations responsible for LCA, especially in the context of genetic counseling for
individual patients in a clinical setting.
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Introduction
Leber congenital amaurosis (LCA, MIM 204000) is a severe
form of inherited retinal dystrophy, characterized by severe visual
loss at or near birth, Franceschetti’s oculo-digital sign, searching or
wandering nystagmus, and pigmentary retinopathy [1,2]. Visual
acuity is rarely better than 20/400 [3]. Fundus changes are
extremely variable, ranging from a normal appearance to an
obvious pigmentary retinopathy similar to retinitis pigmentosa.
Electroretinogram (ERG) recordings are usually extinguished or
severely subnormal. In most cases, LCA shows an autosomal
recessive pattern of inheritance. However, several families with
autosomal dominant LCA have been well documented [2]. The
prevalence of LCA is around 1–2 per 80,000 live births,
accounting for approximately 20% of cases of inherited blindness
among children and more than 5% of all congenital retinopathies
[4]. Currently, 16 loci for LCA have been mapped, at which
mutations in 15 genes have been identified as being responsible for
the disease: GUCY2D [5], CRB1 [6], RPE65 [7], RPGRIP1 [8],
AIPL1 [9], LCA5 [10], CRX [11], LRAT [12], TULP1 [13], RDH12
[14], CEP290 [15], RD3 [16], SPATA7 [17], IMPDH1 [18], and
MERTK [19].
It has been estimated that mutations in these 15 genes are
responsible for about 65% of all LCA cases [2]. The most
frequently mutated genes in published studies are CEP290 (15%),
followed by GUCY2D (12%), CRB1 (10%), RPE65 (6%), AIPL1
(5.3%), RPGRIP1 (4.2%), LCA5 (1.8%), CRX (1.0%), and MERTK
(0.6%). However, the full frequency spectrum of variation in these
15 genes has not been evaluated in East Asia, an area containing
one third of the world’s population. In this study, we performed a
comprehensive evaluation of variation in these 15 genes in 87
unrelated Han Chinese patients with LCA.
Methods
LCA Patient cohort
Eighty-seven unrelated patients with LCA were recruited at the
Pediatric and Genetic Clinic in the Eye Hospital of Zhongshan
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Chinese ethnicity and lived in southern China. Of the 87 patients,
75 were isolated cases, 9 were from families with autosomal
recessive LCA, and 3 were from families with autosomal dominant
LCA. Genomic DNA from each patient was prepared from
leukocytes of peripheral venous blood by whole blood lysis,
followed by phenol-chloroform extraction and ethanol precipita-
tion. The DNA pellet was dissolved in TE buffer (pH 8.0).
Genomic DNA was also obtained from 96 unrelated healthy Han
Chinese individuals with normal corrected visual acuity and no
symptoms or family history of retinal degeneration.
Ethics
Written informed consent was obtained from participants before
the study, conforming to the tenets of the Declaration of Helsinki
and following the Guidance for Sample Collection of Human
Genetic Disease (National 863-Plan) by the Ministry of Public
Health of China. This study was approved by the Institute Review
Board of the Zhongshan Ophthalmic Center and the National Eye
Institute.
Mutation screening
The most frequently mutated exons in the 15 genes, plus one
intron, were selected based on previous reports for the initial scan
for variation in the 87 patients [2]. The primer pairs (Table S1)
used to amplify genomic fragments encompassing each of the
exons and the adjacent 100 bp or more flanking intronic regions
were designed using Primer 3 (http://frodo.wi.mit.edu/primer3/).
PCR amplifications were carried out in 10-ml reactions containing
40 ng genomic DNA. Touchdown PCR amplification consisted of
a denaturizing step at 95uC for 5 minutes, followed by 35 cycles of
amplification (at 95uC for 30 seconds, at 64,57uC for 30 seconds
starting from 64uC with decreasing by 0.5uC every cycle for 14
cycles until remaining at 57uC for 21 cycles, and at 72uC for 40
seconds), and a final extension at 72uC for 10 minutes. The
amplicons were sequenced with an ABI BigDye Terminator cycle
sequencing kit v3.1 (Applied Biosystems, Foster City, CA),
electrophoresed on an ABI3100 or ABI 3130 Genetic Analyzer
(Applied Biosystems, Foster City, CA), and analyzed with Seqman
software (Lasergene 8.0, DNASTAR, Madison, WI) or Mutation
Surveyor (SoftGenetics, State College, PA).
Subsequently, all the remaining exons in 11 of the 15 genes
(GUCY2D, CRB1, RPE65, RPGRIP1, AIPL1, LCA5, CRX, SPATA7,
CEP290, RDH12 and MERTK) were amplified and sequenced for
all patients. For the remaining 4 genes including TULP1, RD3,
LRAT, and IMPDH1, because of the rarity of reported variation in
these genes and exons, only exons with previously reported
variants were analyzed. The exons analyzed in our initial scan and
subsequent analyses are listed in Table 1.
A variant was predicted to be pathogenic if it was predicted to
be damaging by Blosum 62, predicted to be possibly damaging (a
value of 1.5 or greater) by the position specific independent counts
algorithm of Polyphen [20], had a SIFT score (which distinguishes
tolerated variants from those that are not tolerated) equal to or less
than 0.05, and was absent in 192 ethnically matched control
chromosomes. Splicing changes were predicted by Automated
Splice Site Analyses (https://splice.uwo.ca/).
Results
Fifty-three different variants were identified in 44 of the 87
patients (50.6%), involving 78 of the 88 alleles (11 homozygous
and 56 heterozygous) (Tables S2 and S3). These include 8
homozygous or 12 compound heterozygous cases, 5 cases in whom
two mutations in one gene and a single mutation in a second gene
were identified (triallelic), 3 patients in whom two mutations in
different genes were identified (digenic), and 16 patients in whom
only a single heterozygous variant was identified. Of the 53
variants identified, 35 (66%) were novel and predicted to be
pathogenic, 9 (17%) were known to be pathogenic, and 9 (17%)
were novel neutral or unknown effects. An initial scan of 55
amplicons (out of 215 in total, 25.6%) detected 83.3% (65/78) of
the mutant alleles detected by the full scan. Sequencing the
remaining exons in 11 of the 15 genes detected only 13 additional
mutant alleles (16.9%).
The percentage of patients who had variants in the 15 genes
were, in decreasing order: GUCY2D 16.1% (14/87), CRB1 11.5%
(10/87), RPGRIP1 8% (7/87), RPE65 5.7% (5/87), SPATA7 4.6%
(4/87), CEP290 4.6% (4/87), CRX 3.4% (3/87), LCA5 2.3% (2/
87), MERTK 2.3% (2/87), AIPL1 1.1% (1/87), and RDH12 1.1%
(1/87) (all variants were taking into account for those patients who
had variants in more than one gene). For individual genes, the
majority of variants were found in one exon (RPE65, CRX, LCA5,
AIPL1, and RDH12), two exons (CRB1, RPGRIP1, SPATA7,
CEP290 and MERTK), or three exons (GUCY2D) (Table 2).
Further analysis revealed that 9 exons (4.19% fragments
sequenced, 9/215) contained 50.8% (39/78) of the variant alleles
detected in this study (Table S4). Polymorphisms detected in these
genes are shown in Table S5. Clinical data for the 44 patients in
which variants were found were listed in Table S6.
GUCY2D
Fifteen GUCY2D variants (including13 novel variants) were
identified in 14 LCA patients (Tables S2 and S3). Variants were
found in the homozygous, compound heterozygous, and hetero-
zygous states in 4, 5, and 5 patients, respectively. Of these 14
patients, 6 also had variants in other genes, carrying 2, 3, 4 variant
alleles overall. The c.164C.T (p.T55M) variant was found in four
patients (one homozygote and three heterozygotes), suggesting an
existence of mutation hot spot at this site, since each of those
patients have different local SNP haplotypes (data not shown). The
Table 1. The exons and one intron sequenced in our initial
screen and in subsequent analyses.
Gene
Total number
of exons
Exons for
initial scan
Exons for subsequent
sequencing
GUCY2D 19 2, 3, 8–12,15–17 All remaining
CRB1 12 2,6,7,9,11 All remaining
RPGRIP1 24 2–4,12,15,16, 21–23 All remaining
SPATA7 12 8,11,12 All remaining
RPE65 14 3,4,9,10 All remaining
CRX 3 3 All remaining
LCA5 7 1,2,7 All remaining
AIPL1 6 2,5,6 All remaining
RDH12 7 5 All remaining
CEP290 54 IVS26+1665, 36, 41 All remaining
MERTK 19 4,7,14,15,19 All remaining
IMPDH1 17 6–8 None
LRAT 3 2 None
RD3 3 2 None
TULP1 15 12–14 None
doi:10.1371/journal.pone.0019458.t001
Half Mutations Detected in 9 Exons of 15 LCA Genes
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have been described previously. The most frequently mutated 10
exons contained 86.9% (20/23) of the mutant alleles detected by
sequencing all 19 coding exons. Variants were most frequent in
exon 2 (7 variants found in 6 patients), followed by exons 11 and
12. Besides, several polymorphisms were detected, including
c.61T.C (p.W21R), c.154G.T (p.A52S), and c.2101C.T
(p.P701S), respectively (Table S5). The c.61T.C (p.W21R) was
reported as a polymorphism [21] even though PolyPhen predicted
it to be possibly damaging. No variants were found in exons 1, 5–
7, 10, 13–15, 18, or 19 (Table 2).
CRB1
Nine variants (7 novel variants) were detected in 10 patients
(Tables S2 and S3), including 5 missense, 3 splicing, and 1
nonsense variant(s). The c.866C.T (p.T289M) variant in patient
LH7 was reported as a pathogenic mutation based on a study of
Italian patients [22], although it was predicted to be benign by
Polyphen and tolerated by SIFT. However, it was found not to co-
segregate with the disease in another study [23], suggesting it has a
nonpathogenic role. The heterozygous variant c.4005+2T.Gi n
LH29 was predicted to abolish the splicing site, with Automated
Splice Site Analysis predicting that binding energy would be
decreased to 0, and on that basis is predicted to be responsible for
disease. The heterozygous 1903T.C (p.S635P) variant in LH29
might be a neutral based on the prediction of Polyphen and SIFT.
Patient QT453 and LH16 carried putative triallelic variants
(Tables S2 and S3). In our initial scan, sequencing 5 out of the 12
exons detected 94.1% of the mutant alleles (16/17) (Tables 1 and
2). A novel missense variation, c.664G.A (p.E222K), was
considered to be an undiscovered polymorphism due to its
presence in 3 normal controls. Variants were most often located in
exons 6, 9, and 11 (Table 2) but were absent in exon 1, 3, 5, 10,
and 12.
RPGRIP1
Eight novel RPGRIP1 variants were identified in 7 patients,
including 7 pathogenic mutations and 1 putatively neutral variant.
Of the 7 patients, 3 had a single heterozygous variant and 3 were
compound heterozygotes. The other patient, RP208, had four
variants in three genes: a homozygous c.535delG (p.E179SfsX10)
variant in RPGRIP1, a heterozygous c.1312C.T (p.R438C)
variant in GUCY2D, and a heterozygous c.295G.A (p.V99I)
variant in RPE65. The novel c. 3388G.C (p.E1130Q) variant in
individual QT654 was predicted to be neutral by both PolyPhen
and SIFT. Most of these variants occurred within the RPGR
interacting domain. The efficiency of the initial screening was 90.1
% (10/11 alleles) (Tables 1 and 2). In addition, three known
polymorphisms were detected in LCA patients (Table S5).
Variants were most frequent in exon 3 (Table 2), and no variation
was found in exons 1, 2, 6, 8–11, 16–20, 22, and 24.
RPE65
Three variants were detected in 5 patients, including one known
(c.1059_1060insG/p.K354EfsX11) [24] and two novel variants
(c.295G.A/p.V99I, c.997G.C/p.G333R) (Table S2). The two
novel variants were predicted to be neutral by PolyPhen and
SIFT. Four patients carried the same heterozygous c.295G.A
(p.V99I) variant that is absent in 96 normal controls. One patient
was a compound heterozygote for two mutations (c.997G.C and
c.1059_1060insG). Our initial scan of 4 of the 14 exons detected
100% of the variant alleles (6/6) identified after sequencing all 14
exons.
SPATA7
Three variants in 4 patients were found in SPATA7, 2 were
novel and 1 known (Tables S2 and S3). Two variants were
predicted to be pathogenic and the c.995T.C (p.I332T) variant
was predicted to be neutral by Polyphen and SIFT. The variants
were heterozygous in three patients and homozygous in one
patient. Patient LH15 was heterozygous for a known 4 bp deletion
in SPATA7 and a common missense mutation in GUCY2D
(p.T55M). Our initial scan on 3 of the 12 exons could find 60%
of the mutant alleles (3/5) detected after all 12 exons were
sequenced.
CEP290
First, we analyzed the genomic regions encompassing
IVS26+1655, exon 36, and exon 41 of CEP290, where the
c.2991+1655A.G is the most common mutation in Caucasians.
However, no variation was detected in the 87 Chinese patients,
except for a presumably neutral variant, c.5709+25A.C.
Five variants in the other CEP290 exons were subsequently
detected in 4 patients, including 4 that were novel (c.367C.T,
c.4897C.T, c. 6766delC, and c.6787A.G) and 1 that was
previously described (c.383_386delATAG). Two patients were
Table 2. Frequencies of variant alleles detected in the individual exons of each gene.
Gene Exons in decreasing order (%)
GUCY2D Exon 2 (30.4) Exon 11 (13.1) Exon 12 (13.1) Exon 3 (8.7) Exon 4 (8.7) Exon 8 (8.7) Exon 9 (8.7) Exon 16 (4.3) Exon 17 (4.3)
CRB1 Exon 6 (35.3) Exon11 (29.4) Exon 9 (23.5) Exon 7 (5.9) Exon 4 (5.9)
RPGRIP1 Exon 3 (36.3) Exon 4 (18.2) Exon 5 (9.1) Exon 12 (9.1) Exon 15 (9.1) Exon 21 (9.1) Exon 23 (9.1)
SPATA7 Exon 2 (40) Exon 11 (40) Exon 8 (20)
CEP290 Exon 6 (50) Exon 37 (16.7) Exon 42 (16.7) Exon 49 (16.6)
RPE65 Exon 4 (66.6) Exon 9 (16.7) Exon 10 (16.7)
CRX Exon 3 (66.7) Exon 2 (33.3)
LCA5 Exon 7 (50) Exon 2 (50)
AIPL1 Exon 6 (100)
MERTK Exon 4 (50) Exon 19 (50)
RDH12 Exon 3 (100)
doi:10.1371/journal.pone.0019458.t002
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gotes. The effect of the c.6787A.G (p.S2263G) variant could not
be predicted by PolyPhen but SIFT labeled it as damaging (Tables
S2 and S3).
CRX
Three heterozygous variants in CRX were identified in 3
patients (Tables S2 and S3). All 3 variations are predicted to be
pathogenic. Of the 3, the c.541delG (p. A181PfsX5) variant in
patient LH9 and the c.458delC(p.P153QfsX34) variant in RP178
were reported by our previously study [25,26].
LCA5
Two novel heterozygous variants in LCA5 were identified in two
patients, respectively (Tables S2 and S3). The 1820_1821delCA
(p.Q607VfsX6) variant in exon 7 is predicted to cause a frameshift
and the c.634G.T (p.A212S) variant in exon 2 is predicted to be
benign by both PolyPhen and SIFT. Additionally, two known
polymorphisms, p.D26A and p.G656D, were found in 35 and 32
patients, respectively (Table S5).
AIPL1
A novel homozygous variant, c.926_927insCCTGAACCG-
CAGGGAGCT (p. E309DinsLNRREL), was identified in patient
QT338 (Tables S2 and S3). In addition, a known polymorphism,
c.268G.C (p.D90H), was detected in 31 patients (Table S5).
RDH12
One novel heterozygous c.236C.T (p.A79V) variant was
detected in patient LH16, and was predicted to be benign (Tables
S2 and S3). In addition, p.R161Q, a known polymorphism, was
detected in 3 patients (Table S5).
MERTK
Two novel heterozygous variants in MERTK were identified in
patients LH28 and RP143. Both of them are predicted to be
pathogenic. Sequencing revealed that patient RP143 was
heterozygous at two sites: c.2873C.T (p.P958L) in MERTK and
c.6787A.G (p.S2263G) in CEP290 (Tables S2 and S3).
TULP1, RD3, LRAT and IMPDH1
Unlike the other 11 genes listed above, for which all coding
exons were analyzed by sequencing, only those exons with
previously reported variants were analyzed in TULP1, RD3,
LRAT, and IMPDH1, due to the rarity of reported variants in the
exons of these genes. No variants were detected in any of the exons
screened in these genes, including exons 12–14 of TULP1, exon 2
of RD3, exon 2 of LRAT, and exons 6–8 of IMPDH1.
Discussion
Leber congenital amaurosis is the earliest occurring and most
severe inherited retinal dystrophy. Since the initial identification of
mutations to GUCY2D as a cause of LCA in 1996 [5], mutations in
a total of 15 genes have been identified as being responsible for
LCA, accounting for approximately 65%–70% of LCA cases
[2,27,28]. However, the variant frequencies for these genes vary
between different ethnic groups. In northern Pakistan, the genes
most commonly mutated in LCA are RPGRIP1 (29% of families),
AIPL1 (21% of families), and LCA5 (21% of families); whereas in
Caucasian populations, mutations in RPGRIP1, AIPL1, and LCA5
account for only 4.2%, 5.3%, and 1.8% of LCA cases, respectively
[2]. Although CEP290 is the most commonly identified mutant
gene in Caucasian LCA patients, accounting for 15% of LCA
cases [29], mutations in CEP290 have not been detected in LCA
patients from Korea [30], Saudi Arabia [31], northern Pakistan
[32], or southern India [33]. An understanding of the frequency
spectrum of variants in these 15 genes in different populations will
not only facilitate genetic diagnosis and genetic counseling for this
disastrous disorder, but will also identify patients who may
potentially benefit from gene therapy or other possible interven-
tions [31]. Because the NPHP5 gene was only recently reported as
related to LCA by Stone EM, et al [34], this gene was not included
into our study.
Here, we performed comprehensive mutational analysis of 15
genes in 87 unrelated Chinese patients with LCA. Of the 15 genes,
all coding exons in 11 genes were analyzed by cycle sequencing.
For the remaining 4 genes which have only infrequently been
identified as causal for LCA, only exons in which variants had
previously been identified were sequenced. The percentage of
patients who had variants in the 15 genes were, in decreasing
order: GUCY2D 16.1% (14/87), CRB1 11.5% (10/87), RPGRIP1
8% (7/87), RPE65 5.7% (5/87), SPATA7 4.6% (4/87), CEP290
4.6% (4/87), CRX 3.4% (3/87), LCA5 2.3% (2/87), MERTK 2.3%
(2/87), AIPL1 1.1% (1/87), and RDH12 1.1% (1/87). Thus, the
frequencies of variants in different genes vary remarkably in
different populations. GUCY2D was the gene most frequently
mutated in Chinese patients while the genes found to be most
frequently mutated in other populations were RPGRIP1 in people
from northern Pakistan [32], CRB1 in the Spanish [28], and
CEP290 in Caucasians [15]. The overall rate variant detection was
50.6% (44/87) in this study, which is comparable to the worldwide
variations detection rate of 65% if the difference between the
frequency of variants in CEP290 is taken into consideration
(CEP290 mutations occur in 15% of Caucasian patients but in only
in 6.4% of Chinese patients) [2].
Homozygous mutations were identified in a number of cases,
often related to the family and population structure. For
example, family LH22 was having homozygous T55M muta-
tions in GUCY2D, families LH32 and QT585 showing
homozygous S611P mutations in CRB1,a n df a m i l yR P 2 0 8
showing a single base deletion in RPGRIP1 are from consan-
g u i n e o u sm a t i n g si na ni s o l a t e dC h a o s h a np o p u l a t i o n .F a m i l i e s
QT521 and QT608 showing splicing and M784R mutations in
GUCY2D respectively, family LH24 with a R395X mutation in
SPATA7 and family QT338 showing an 18 base pair insertion in
AIPL1 are not know to be consanguineous, but are from isolated
populations.
Identifying the most frequently mutated exons in these 15 genes
will greatly facilitate detection of variation in LCA patients in a
clinical testing. Our initial scan of 25.6% (55 of 215) of exons,
based on the frequencies of variation in other populations,
detected 83.3% (65/78) of all the mutant alleles we detected.
This indicates that reducing the amount of labor and cost by 75%
would still result in detection of over three quarters of the variation
in our samples. Based on our study of 87 Chinese patients,
sequencing only the 9 most polymorphic (4.18% of the 215
sequenced regions) exons (exons 2, 11, and 12 of GUCY2D; exons
6, 11, and 9 of CRB1; exon 4 of RPE65; exon 3 of RPGRIP1; and
exon 6 of CEP290) would result in detection of 50.8% (39/78) of
all variants found in this study. This would use less than 5% of the
labor and cost of a comprehensive sequencing strategy and detect
over 50% of the variation present in other groups of Chinese
patients. Screening these exons in order of amount of expected
variation would be predicted to cut expenses significantly while
still being accurate and comprehensive. Our results provide a key
bridge between bench and bed side and should make genetic
Half Mutations Detected in 9 Exons of 15 LCA Genes
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practical. This should greatly enhance the clinical genetic
counseling, diagnosis, and early intervention of LCA in the
Chinese population. These results also highlight the importance of
analyzing the causative genes and their exons in different ethnic
groups in a systematic and population-specific fashion.
Another important point from our study is that some sequence
variations might mistakenly be thought to be causative mutations
for LCA if only a single individual gene were analyzed. For
example, the heterozygous c.164C.T (p.T55M) variant in
GUCY2D might be incorrectly labeled a common mutation for
LCA because it was found in 3 unrelated patients with LCA but
not in 96 controls, was predicted to be a pathogenic mutation by
Polyphen, and was identified as a causative mutation in SIFT.
This might be the case for patient LH22, who had homozygous
c.164C.T mutations, but it may not cause LCA in patient
QT453 since QT453 had homozygous nonsense mutations
(G1226X) in CRB1. Even though both mutations themselves
could be pathogenic, digenic mutations may not necessarily cause
disease, since one of the phenotypically normal parents in families
LH16, QT479, QT453, QT509, and RP208 presumably carry
digenic mutations. In this study, digenic variants were detected in
3 patients, including LH15 (GUCY2D and SPATA7), QT659
(CRB1 and LCA5), and RP143 (CEP290 and MERTK). Whether
these mutations are indeed causative and what types of digenic
variations may be responsible for LCA needs additional study.
For the 5 patients (LH16, QT479, QT509, QT453, and RP208)
with 3 or 4 variants in two or 3 genes, their clinical phenotypes
are comparable to patients with homozygous or compound
heterozygous mutations in a single gene (Table S6), suggesting
that the third or fourth mutant allele may not have an additive
effect and may be more likely to act as a benign variant. In such
cases, the 6 additional variant alleles in these 5 patients should
not be counted toward the total number of mutant alleles and,
therefore, the adjusted number of mutant alleles detected should
be 72, not 78 (from 44 patients). In an earlier genotyping
microarray study, Zernant, et al. determined 7.3% of LCA
patients carry a third mutant allele [35], a greater fraction than
would be expected by chance. On the other hand, single
heterozygous variants were detected in genes known to cause
autosomal recessive LCA in 16 patients (15 predicted to be
pathogenic mutations and 1 predicted to be neutral). This might
simply represent a failure to detect a second variant. Conversely,
it is possible that neutral or silent variants or polymorphisms in
the 15 genes sequenced here or in other genes might serve as
disease modifier alleles with another major gene defect occurring
simultaneously [36]. Additional comprehensive studies, or
perhaps further work with animal models, are necessary to
answer this question.
In conclusion, systematic analysis of the full frequency spectrum
of variation in the 15 selected genes not only gives us an overview
of the molecular etiology of LCA in Chinese but also provides
useful biomarkers for genetic counseling. In the near future,
patients in whom pathogenic mutations are identified could
become potential participants for gene therapy, and thus,
identification of efficient and effective diagnostic approaches
based on the population genetics specific to the patient will
become increasingly important.
Supporting Information
Table S1 Primers used for sequencing. This table listed
340 primers used to amplify genomic fragments of the GUCY2D,
CRB1, RPE65, RPGRIP1, AIPL1, SPATA7, LCA5, CRX, RDH12,
CEP290, IMPDH1, TULP1, and MERTK genes.
(XLS)
Table S2 Variants detected in the 15 genes sequenced in
87 unrelated LCA patients and 96 healthy controls.
Mutations in each gene were listed separately. a) The value is the
difference between the original value and substitution value. b)
These changes are likely neutral variations based on computa-
tional prediction. c) Controversial, as some reports regard this
mutation as a non-pathogenic mutation, den Hollander et al
2004.
(XLS)
Table S3 Variants detected in the 15 genes sequenced in
87 unrelated LCA patients and 96 healthy controls.
Patients with muations were separated into three groups. Group
A: Patients with homozygous or compound heterozygous
mutations in one gene. Group B: Patients with only one
heterozygous mutation in one gene. Group C: Patients with
Digenic or Triallelic or 4 variants. a) The difference between the
original value and the substitution value. b) These variants are
likely neutral variations based on computational prediction. c)
Controversial, as some reports regard this mutation as an non-
pathogenic mutation, den Hollander et al 2004.
(XLS)
Table S4 Frequencies of the 78 variant alleles in
individual exons. The frequency of mutations in each exon
was calculated based on either all mutant alleles in all 15 genes or
those in individual gene.
(XLS)
Table S5 Polymorphisms detected in 87 unrelated LCA
patients and 96 healthy controls. ND: not determined. a)
The c.2101C.T (p.P701S) variant in GUCY2D has been reported
to cosegregate with LCA in three pedigrees (Zernant et al., 2005).
This variant was found at similar frequencies in the patients and
the normal controls in our study (28 heterozygotes and 1
homozygotes out of 87 LCA patients and 26 heterozygotes and
2 homozygote in 96 normal controls). The high frequency of this
variant, and especially its occurrence in a heterozygous state in
normal controls, argues strongly against its classification as a
mutation (Vallespin et al., 2007).
(XLS)
Table S6 Clinical data for the 44 patients who carry
variants in the 15 sequenced genes. FMB=First few months
after birth *Cons=consanguinity marriage of parents. The boy
and his father are both affected. # Both of the twins are affected.
PV=poor vision; PP=photophobia; NB: Night blindness;
NYS=nystagmus; ODS=oculodigital sign; RN=roving nystag-
mus; AV=attenuated vesseles; CRD=carpet-like retinal degen-
eration; PIG=pigment deposit; NFR=no foveal reflex; MA:
Macular atrophy.
(XLS)
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